Established on May 30, 1960, the Department of Nuclear Medicine at Seoul National University Hospital consists of medical departments, such as the in vivo (imaging) laboratory, in vitro (specimen) laboratory, pediatric nuclear medicine laboratory, and tumor nuclear medicine laboratory (PET center), along with research and administrative teams. Including five professors specializing in nuclear medicine, and three professors specializing in radiopharmaceuticals, nuclear medicine physics, and molecular imaging medicine, there are a total of 100 employees. Among these are visiting professors, research professors, clinical instructors, doctors, nurses, pharmacists, radiologists, clinical pathologists, administrative staff, and researchers. Under the motto of "Harmony and Cooperation, Creativity and Challenge, and Global Leadership," radioactive isotopes are applied to the diagnosis and treatment of diseases, and consultation, education, and research are actively in progress.
The Department of Nuclear Medicine employs state-of-the-art equipment, such as 3 PET/CT, 1 PET/MRI, and 10 gamma cameras to annually perform 50,000 imaging tests, 700,000 specimen tests using radioimmunoassay, and 1,000 cases of treatment using radioisotopes. In particular, it has gained world-class achievements in research areas. In addition to the clinical research in nuclear medicine, it has achieved academic excellence by performing a wide range of research from basic to clinical studies in such areas as nuclear science, molecular imaging, and nuclear medicine-based fusion research, and publishes 50 to 60 papers annually in SCI-listed international journals.
Recognized by the International Atomic Energy Agency (IAEA) in May 2005 for its world-class excellence in research and treatment, the department was designated as the only nuclear medicine and molecular imaging cooperation center in the field of nuclear medicine in the world. In addition, it has conducted educational projects for the development of nuclear medicine in developing countries in cooperation with the IAEA, greatly contributing to promoting nuclear medicine around the world.
In terms of international leadership, Prof. Myung-cheol Lee (currently emeritus professor) served as president of the World Federation of Nuclear Medicine and Biology when the Republic of Korea hosted the 9th World Congress of Nuclear Medicine in 2006. In 2019, Professor Dongsoo Lee is again leading the global development of nuclear medicine as president of this same federation. For the development of nuclear medicine in developing countries, the International Go Changsoon Fellowship has been playing a global leading role in nuclear medicine since 2010. Since the late 2010s, it has been raising the standard of nuclear medicine in Korea by introducing nuclear medicine treatment technology for intractable diseases, and promoting basic and intervention research, and carrying out clinical trials.
-Education: Training clinical instructors, medical residents, staff, students, and clinical trainees
-Research: Development of various radiopharmaceuticals and diagnosis/treatment methods
-Consultation/treatment: Treatment of thyroid disease through radioactive iodine and nuclear medicine Target treatment through targeted radiopharmaceuticals
-Tests: Nuclear medicine imaging, fusion imaging, and various radioimmunoassay methods